Savient Pharmaceuticals, Inc. (VNT) Earnings
|
Expand Research on VNT
| Next EPS Date | 10/29/26 | EPS Growth Rate | +7.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.1% | Revenue Growth Rate | -3.0% |
| Average % Move 1-Wk after EPS | -6.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | $0.84 | N/A | N/A | $730.5M | = | N/A | N/A | ||
| 8/6/26 |
Q226 | $0.89 | $0.81 | +$0.08 | $756.7M | $743.95M | = |  | | Details | |
| 5/7/26 | Q126 | $0.80 | $0.80 | $0.00 | $750.6M | $737.08M | = | | | Details | |
| 2/12/26 | Q425 | $0.86 | $0.85 | +$0.01 | $808.5M | $764.99M | = | | | Details | |
| 10/30/25 | Q325 | $0.78 | $0.77 | +$0.01 | $753M | $747.9M | = | | | Details | |
| 7/31/25 | Q225 | $0.79 | $0.72 | +$0.07 | $774M | $734.49M | = | | | Details | |
| 5/1/25 | Q125 | $0.77 | $0.72 | +$0.05 | $741M | $722.54M | = | | | Details | |
| 2/13/25 | Q424 | $0.80 | $0.79 | +$0.01 | $777M | $770.79M | = | | | Details |
